Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2007
03/22/2007WO2007030879A1 Diagnostic markers and uses therefor
03/22/2007WO2006130472A3 Identification of rac1b as a marker and mediator of matrix metalloproteinase-induced malignancy
03/22/2007WO2006123254A3 Method for determining phytase activity
03/22/2007WO2006122215A3 Methods of mapping polymorphisms and polymorphism microarrays
03/22/2007WO2006121773A3 Compositions and assays to detect influenza virus a and b nucleic acids
03/22/2007WO2006119419A3 Materials and kits for use in hot-start pcr, and methods of amplifying nucleic acids in a polymerase chain reaction
03/22/2007WO2006117688A3 Diagnosis of heart failure
03/22/2007WO2006113590A3 Flow-cytometric heteroduplex analysis for detection of genetic alterations
03/22/2007WO2006107317A3 Methods for monitoring genomic dna of organisms
03/22/2007WO2006103421A3 Method for predicting the response to receptor tyrosine kinase inhibitors
03/22/2007WO2006099142A3 Prognostic method for vascular diseases
03/22/2007WO2006094056A3 Enzyme amplified electrochemical dna detection
03/22/2007WO2006094041A3 Methods, reagents and kits for reusing arrays
03/22/2007WO2006093529A3 Covalent tethering of functional groups to proteins and substrates therefor
03/22/2007WO2006090073A3 Method and device for separating molecular targets in a complex mixture
03/22/2007WO2006089203A3 Compositions and methods for detecting viral specific nucleic acids in urine
03/22/2007WO2006083516A9 Modified cyanovirin-n polypeptide
03/22/2007WO2006075254A3 Methods and products for in vitro genotyping
03/22/2007WO2006064481A3 Method for universal pcr
03/22/2007WO2006055351A3 Structure-based compound design involving riboswitches
03/22/2007WO2006048291A3 Transcriptome microarray technology and methods of using the same
03/22/2007WO2006036179A3 Frizzled proteins and detection and treatment of cancer
03/22/2007WO2006031544A3 Methods for detection of pathogens in red blood cells
03/22/2007WO2005108990A3 Methods of treating demyelinating disorders
03/22/2007WO2005098033A8 Screening method for identifying pufa pks in samples
03/22/2007WO2005094363A3 System, method and software arrangement for bi-allele haplotype phasing
03/22/2007WO2005084395A3 Method of stabilization of functional nanoscale pores for device applications
03/22/2007WO2005008450A3 Method and apparatus for nanogap device and array
03/22/2007WO2004009837A3 A high resolution typing system for pathogenic mycobacterium tuberculosum
03/22/2007US20070067874 Plants which synthesize a modified starch, process for the production thereof and modified starch
03/22/2007US20070067868 Insect resistant cotton plants and methods of detecting the same
03/22/2007US20070067858 Novel il-8-like polypeptides
03/22/2007US20070067856 Therapeutic agent for NGF
03/22/2007US20070067111 Computer-aided visualization of expression comparison
03/22/2007US20070066804 Polypeptide of given sequence; inducing HLA (human leukocyte antigen) restricted cytotoxic T lymphocytes
03/22/2007US20070066803 Method to control tumor progression and invasiveness
03/22/2007US20070066801 Identification of reagents for the diagnosis and study of francisella
03/22/2007US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor
03/22/2007US20070066665 Compounds and methods for the diagnosis and treatment of amyloid associated diseases
03/22/2007US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases
03/22/2007US20070066558 Molecular determinants of myeloma bone disease and use thereof
03/22/2007US20070066554 Immunostimulatory nucleic acids
03/22/2007US20070066553 Immunostimulatory nucleic acid molecules
03/22/2007US20070066546 Compositions for the reversible thioesterification of signaling proteins and methods of using same
03/22/2007US20070066543 Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity
03/22/2007US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
03/22/2007US20070065953 Methods for reducing the range in concentrations of analyte species in a sample
03/22/2007US20070065934 Amplification of enzymatic reactions for use with an enthalpy array
03/22/2007US20070065926 Circular site-directed mutagenesis
03/22/2007US20070065925 Vaccine containing cell transformed with a nucleotide sequence of the genome of Porcine circovirus type B
03/22/2007US20070065924 Isolated polynucleotide sequence with IRES activity
03/22/2007US20070065923 Transmissible spongiform encephalopathies (TSE); Creutzfeldt-Jakob disease; immunoassay
03/22/2007US20070065921 Methods and products related to producing low molecular weight heparin
03/22/2007US20070065904 Recombinant expression vectors for functional nav1.9 sodium channels
03/22/2007US20070065899 Staining a yeast population with a stain capable of internal pH (pHi)-dependent fluorescence; determining a gate pH and a corresponding fluorescence parameter of the stained yeast population; sorting the cells of the stained yeast population such that the cells having a pH above the gate pH are retained
03/22/2007US20070065898 Fluorescence polarization assays for binding of caspase inhibitors and probes therefor
03/22/2007US20070065897 Human PRSS11-like S2 serine protease and uses thereof
03/22/2007US20070065896 Methods and kits for quantifying metabolites or analytes
03/22/2007US20070065895 Substrates specific to von willebrand factor cleaving protease and method of assaying the activity
03/22/2007US20070065894 Method for quantification of biological material in a sample
03/22/2007US20070065893 Liquid-phase galactose oxidase-schiff's assay
03/22/2007US20070065892 High throughput assay of lp-pla2 activity
03/22/2007US20070065887 Diagnosis of pre-cancerous conditions using pcdgf agents
03/22/2007US20070065885 Methods for shp1 mediated neuroprotection
03/22/2007US20070065879 Marker for inflammatory conditions
03/22/2007US20070065876 Marking
03/22/2007US20070065875 NTB-A, a surface molecule involved in natural killer cells activity
03/22/2007US20070065874 Compositions and methods comprising control nucleic acid
03/22/2007US20070065873 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators
03/22/2007US20070065872 Apparatus and methods for detecting DNA in biological samples
03/22/2007US20070065871 Human T2R71 receptor and related assays for identifying human bitter taste modulators
03/22/2007US20070065870 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste
03/22/2007US20070065869 Methods for producing ligand arrays
03/22/2007US20070065868 IL-17 receptor like molecules and uses thereof
03/22/2007US20070065866 Suppressing fibrosis in a mammal having a fibrosing disease by administering a Serum Amyloid P (SAP) protein; treatment of diseases such as scleroderma, pulmonary fibrosis and asthma
03/22/2007US20070065865 Polymorphisms Associated with Coronary Artery Disease
03/22/2007US20070065864 Message abundance and allele copy number determination using IVT with single-stranded primer-promoter-selector constructs
03/22/2007US20070065863 Method for detecting a risk of cardiovascular disease
03/22/2007US20070065861 Methods for genetic analysis of alternative splicing
03/22/2007US20070065860 Accelerated class I and class II HLA DNA sequence-based typing
03/22/2007US20070065859 Methods and materials for identifying the origin of a carcinoma of unknown primary origin
03/22/2007US20070065858 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
03/22/2007US20070065857 Optical system for plant characterization
03/22/2007US20070065856 determining expression of a panel of 8 specific biomarker genes; using overexpression of some of these marker genes compared to their expression in normal prostate tissue and the underexpression of the rest of these marker genes are indicative of cancerous prostate tissue
03/22/2007US20070065855 biochip capable of quantitatively grasping hybridization efficiency and comprising a plurality of probe sites with target molecules bonded thereto; using fluorescent light emission
03/22/2007US20070065854 Serum-free medium for producing retroviruses
03/22/2007US20070065853 For detection of nucleic acid marker molecules; used to rapidly identify TSE-infected cattle; amplifying and monitoring the development of specific amplification products
03/22/2007US20070065852 HIV recombinant vaccine
03/22/2007US20070065851 Method for detecting a microorganism in a fecal specimen
03/22/2007US20070065850 Method for diagnosis of heart failure
03/22/2007US20070065849 Nucleic acid encoding eosinophil eotaxin receptor
03/22/2007US20070065848 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
03/22/2007US20070065847 Degeneratively Labeled Probes
03/22/2007US20070065846 Gene expression profiling in biopsied tumor tissues
03/22/2007US20070065845 Gene expression profiling in biopsied tumor tissues
03/22/2007US20070065844 Solution-based methods for RNA expression profiling
03/22/2007US20070065843 Polymorphisms in mitochondrial transcription factor A ("TFAM") gene and their associations with measures of marbling and subcutaneous fat depth in beef cattle
03/22/2007US20070065842 Detection of survivin in the biological fluids of cancer patients
03/22/2007US20070065841 Methods and compositions for the removal of nucleic acid amplification inhibitors
03/22/2007US20070065840 Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAS and their target mRNAS
1 ... 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 ... 3003